IL161674A0 - Methods and means for producing proteins with predetermined post-translational modifications - Google Patents

Methods and means for producing proteins with predetermined post-translational modifications

Info

Publication number
IL161674A0
IL161674A0 IL16167402A IL16167402A IL161674A0 IL 161674 A0 IL161674 A0 IL 161674A0 IL 16167402 A IL16167402 A IL 16167402A IL 16167402 A IL16167402 A IL 16167402A IL 161674 A0 IL161674 A0 IL 161674A0
Authority
IL
Israel
Prior art keywords
methods
translational modifications
predetermined post
producing proteins
proteins
Prior art date
Application number
IL16167402A
Original Assignee
Crucell Holland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/NL2002/000257 external-priority patent/WO2003089468A1/en
Application filed by Crucell Holland Bv filed Critical Crucell Holland Bv
Priority claimed from PCT/NL2002/000686 external-priority patent/WO2003038100A1/en
Publication of IL161674A0 publication Critical patent/IL161674A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16167402A 2001-10-29 2002-10-29 Methods and means for producing proteins with predetermined post-translational modifications IL161674A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/NL2001/000792 WO2003050286A1 (en) 2001-10-29 2001-10-29 Methods and means for producing proteins with predetermined post-translational modifications
PCT/NL2002/000257 WO2003089468A1 (en) 2002-04-19 2002-04-19 Methods and means for producing proteins with predetermined post-translational modifications
PCT/NL2002/000686 WO2003038100A1 (en) 2001-10-29 2002-10-29 Methods and means for producing proteins with predetermined post-translational modifications

Publications (1)

Publication Number Publication Date
IL161674A0 true IL161674A0 (en) 2004-09-27

Family

ID=19760777

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16167402A IL161674A0 (en) 2001-10-29 2002-10-29 Methods and means for producing proteins with predetermined post-translational modifications

Country Status (7)

Country Link
KR (3) KR100602772B1 (en)
CN (1) CN101177700B (en)
AU (1) AU2002224199A1 (en)
IL (1) IL161674A0 (en)
MX (1) MXPA04003940A (en)
WO (1) WO2003050286A1 (en)
ZA (1) ZA200403209B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9244235B2 (en) 2008-10-17 2016-01-26 Foro Energy, Inc. Systems and assemblies for transferring high power laser energy through a rotating junction
TWI532495B (en) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 Pharmaceutical preparation
CN102818896B (en) * 2011-06-09 2014-12-17 北京华大蛋白质研发中心有限公司 Detection method of nitration modification sites based on specific antibodies and antibody capable of specifically recognizing succinyl-CoA: 3-oxoacid CoA transferase (SCOT) nitration sites
EP3382014A1 (en) * 2017-03-29 2018-10-03 CEVEC Pharmaceuticals GmbH Recombinant glycoproteins with reduced antennary fucosylation
US20230331798A1 (en) * 2020-09-22 2023-10-19 Jecho Laboratories, Inc. Glycosylation-modified erythopoietin and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789247A (en) 1994-04-01 1998-08-04 Ballay; Annick Expression in non-tumoral human lymphoblastoid lines with an integrative vector
PT1012319E (en) * 1997-03-27 2005-06-30 Univ British Columbia INSECT EXPRESSION VECTORS
EP1533380B1 (en) * 1999-04-15 2009-11-04 Crucell Holland B.V. Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus

Also Published As

Publication number Publication date
KR20060057648A (en) 2006-05-26
MXPA04003940A (en) 2004-11-29
KR100602772B1 (en) 2006-07-20
ZA200403209B (en) 2005-01-14
KR100737639B1 (en) 2007-07-09
CN101177700A (en) 2008-05-14
WO2003050286A1 (en) 2003-06-19
KR100692784B1 (en) 2007-03-12
KR20050040824A (en) 2005-05-03
CN101177700B (en) 2012-03-21
KR20060057647A (en) 2006-05-26
AU2002224199A1 (en) 2003-06-23

Similar Documents

Publication Publication Date Title
IL149029A0 (en) High mannose proteins and methods for producing the same
GB0208331D0 (en) Proteins
GB0130557D0 (en) Proteins
IL156660A0 (en) Methods for identifying and producing hla-a2 supermotif-restricted peptides
IL161674A0 (en) Methods and means for producing proteins with predetermined post-translational modifications
EP1487874A4 (en) Falp proteins
AU2002341828A1 (en) Enhanced proteins and methods for their use
GB0212067D0 (en) Proteins
HK1062924A1 (en) Methods and means for producing proteins with predetermined post- translational modifications
AU2002307635A1 (en) Methods and means for producing proteins with predetermined post-translational modifications
AU2003270055A8 (en) Neurotransmission-associated proteins
GB0223860D0 (en) Polypeptide methods and means
GB2370039B (en) Producing protein arrays and fusion protein for use therein
GB0106782D0 (en) Polypeptides, methods and means
AU2003300785A8 (en) Carbohydrate-associated proteins
AU2002326909A8 (en) Neurotransmission-associated proteins
GB0130560D0 (en) Proteins
AU2002329235A1 (en) Method for producing microparticles loaded with proteins
GB0214543D0 (en) Proteins
GB0216757D0 (en) Proteins
AU2003295760A8 (en) Organelle-associated proteins
TWI318239B (en) Methods for producing novel medaka and novel medaka
GB0130739D0 (en) Proteins
GB0126787D0 (en) Proteins
GB0120557D0 (en) Proteins